Article
Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1.
Protein science : a publication of the Protein Society - 1 Feb 2016
Qureshi Tihami, Peterson Cynthia B
Abstract excerpt
The serine protease inhibitor (serpin), plasminogen activator inhibitor-1 (PAI-1), is an important biomarker for cardiovascular disease and many cancers. It is therefore a desirable target for pharmaceutical intervention. However, to date, no PAI-1 inhibitor has successfully reached clinical trial, indicating the necessity to learn more about the mechanics of the serpin. Although its kinetics of inhibition have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
